Analyst firms · Barclays · RDNT
Barclays RDNT price target and rating history
RadNet Inc. (RDNT) · Health Care
Barclays rates RadNet Inc. (RDNT) Overweight with a $79 price target, as of its latest action on Sep 6, 2024. It has published 3 rating actions on RDNT since August 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Overweight
- Price target
- $79
- Median target, all firms
- Too few
- Actions on RDNT
- 3
Barclays price target on RDNT
Every Barclays rating on RDNT
- Sep 6, 2024
- Mar 6, 2024
- Aug 12, 2021
Questions about Barclays and RDNT
- What is Barclays's price target for RDNT?
- Barclays's latest stated price target for RadNet Inc. (RDNT) is $79, from its action on Sep 6, 2024.
- What is Barclays's rating on RDNT?
- Barclays rates RDNT Overweight, a bullish rating, as of Sep 6, 2024.
- When did Barclays last change its view on RDNT?
- On Sep 6, 2024, Barclays upgrades to Overweight from Equal Weight, price target $57 to $79.
More RDNT rating histories
All Barclays ratingsRDNT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.